Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing ...

Germany’s growers have started to cut their Christmas trees in anticipation of a tradition that’s around 500 years old.

Amazon contributed to market strength as its shares gained more than 5% following a $38 billion multiyear deal with OpenAI ...

Lambert, a critically endangered African penguin, has moved to a special geriatric island at the New England Aquarium in ...

Moderna (MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...

UnitedHealth ( UNH) also beat Wall Street estimates for its Q3 results and raised its FY25 EPS guidance. The company reported ...

The world's largest online retailer got a lift from its booming cloud computing business on Friday, Oct. 31, 2025, while a soft sales outlook weighed on a medical device firm's stock.

Moderna is down 35.3% since the beginning of the year, and at $27.16 per share, it is trading 50.3% below its 52-week high of ...

The health plan sector is in a selloff phase again. Cigna (CI) lost 17.39% on Thursday after posting Q3/2025 results. Cigna ...

Moderna was the only company to participate in the public procurement tender for Covid-19 vaccines, meaning that Hungarian can once again be vaccinated against coronavirus with Moderna vaccines during ...

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...